IP Verse

Methods For Treating Myelodysplastic Syndromes And Sideroblastic Anemias

Patent No. EP3226887 (titled "Methods For Treating Myelodysplastic Syndromes And Sideroblastic Anemias") was filed by Acceleron Pharma on Dec 3, 2015. The application was issued on Mar 27, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
WUESTHOFF & WUESTHOFFDec 20, 2024WICHMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3226887

ACCELERON PHARMA
Application Number
EP15865103A
Filing Date
Dec 3, 2015
Status
Granted And Under Opposition
Feb 23, 2024
Publication Date
Mar 27, 2024
External Links
Slate, Register , Google Patents